Helen Tayton-Martin

Company: Adaptimmune

Job title: Chief Business Officer

Seminars:

Industry Leaders’ Fireside Chat: The Opportunity for Next-Gen 8:40 am

Instilling the importance for innovative platforms and technologies to further enhance cell therapy efficacy Reviewing clinical advances of next generation programmes across solid tumours and autoimmunityRead more

day: Conference Day 1 - AM